Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Says Axitinib Trial Met its Primary Endpoint
Pfizer Says Axitinib Trial Met its Primary Endpoint
Pfizer Says Axitinib Trial Met its Primary Endpoint
Submitted by
admin
on November 19, 2010 - 1:38pm
Source:
Bloomberg
News Tags:
Axitinib
Pfizer
clinical trials
cancer
Headline:
Pfizer Says Axitinib Trial Met its Primary Endpoint
Do Not Allow Advertisers to Use My Personal information
